Nov. 20, 2008-The European Medicines Agency has recommended the suspension of the marketing authorisation of Ionsys (fentanyl hydrochloride), from Janssen-Cilag International NV, because of a defect with the delivery system of the medicine that could lead to patients being overdosed.
The details can be read here.
No comments:
Post a Comment